We have 2 of 30 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
INTRODUCTION The oncological benefit of neoadjuvant androgen deprivation therapy (nADT) in high-risk prostate cancer patients has not been proven. The effect of nADT on long-term functional outcomes, namely urinary continence and potency, after radical prostatectomy (RP) is unknown. PATIENTS AND METHODS This retrospe...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
